425: Strive, Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are pursuing a business combination, with Strive issuing Class A common stock to Semler Scientific stockholders.

Summary

• Strive, Inc. and Semler Scientific, Inc. are proposing a business combination.
• Strive will issue additional shares of its Class A common stock to Semler Scientific stockholders as part of the transaction.
• The communication regarding this proposed combination was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on October 28, 2025.
• The filing emphasizes that statements made are forward-looking and subject to inherent risks and uncertainties.
• A Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, will be filed with the SEC to register the Class A common stock and seek approval from Semler Scientific stockholders.

Sentiment

Score: 6

Explanation: The filing announces a significant strategic move (merger) with anticipated benefits, but also clearly outlines numerous material risks and potential dilution, leading to a neutral-to-slightly-positive sentiment.

Positives

• Anticipated strategic benefits and financial benefits from the proposed transaction.
• Expected positive impact on the combined company's future financial performance.
• Potential for anticipated cost savings and strategic gains.

Negatives

• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Possible changes in Strive's or Semler Scientific's share price before closing of the transaction.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits, including cost savings and strategic gains, are not realized when expected or at all, including risks associated with Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Other factors, including unknown or unpredictable factors, that could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Management anticipates strategic and financial benefits from the proposed business combination, expecting a positive impact on the combined company's future financial performance. The timing of the closing of the proposed transaction and the ability to successfully integrate the combined businesses are key forward-looking aspects.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

The filing highlights the strategic benefits of the proposed transaction, including the mention of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets. This suggests a broader industry trend where companies are exploring or integrating digital assets into their financial strategies, potentially positioning the combined entity within this evolving landscape.

Stakeholder Impact

• Shareholders of Strive: Face potential dilution due to the issuance of new Class A common stock.
• Shareholders of Semler Scientific: Will receive Strive Class A common stock, subject to the transaction's terms and approval.
• Customers: Potential for adverse reactions or changes to business relationships.
• Employees: Potential for changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Recommendation

The proposed business combination between Strive and Semler Scientific is a significant strategic development with potential long-term benefits, including strategic gains and cost savings. However, the filing also highlights substantial risks, such as integration difficulties, potential dilution for Strive shareholders, and adverse reactions from stakeholders. Without detailed financial projections, synergy estimates, and a clear valuation of the combined entity, a 'hold' recommendation is prudent. Investors should await the filing of the Form S-4 and proxy materials for a more comprehensive understanding of the financial implications and integration plan before making a definitive investment decision.

Keywords

Strive Inc, Semler Scientific, Merger, Business Combination, Acquisition, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance